previous compound ID: 1529 next compound
InChIKey: NWIBSHFKIJFRCO-WUDYKRTCSA-N
SMILES: CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "SD Macknight" "B Kus" "R Robert" "D Rotin" "GW Carlile" "DY Thomas" "J Goepp" "J Liao" "E Matthes"

chemical graph of compound 1529





CID is 5746
synonyms found at PubChem are:
mitomycin C, Mitomycin, 50-07-7, Ametycine, Mutamycin, Mitocin-C, Ametycin, Mitomycin-C, Mitomycinum, Mytomycin, Mytozytrex, Mitozytrex, Mitomycinum C, Mitocin C, Mitomycins, Mitamycin, MMC, Mitosol, 7-Amino-9alpha-methoxymitosane, Mitomycyna C, NSC-26980, Mitomycyna C [Polish], Mito-C, Mit-C, Mitomicina, Mitomycine, Mitomycin (TN), Mitomycine [INN-French], Mitomycinum [INN-Latin], Mitomicina [INN-Spanish], Muamycin, NCI-C04706, RCRA waste number U010, NSC26980, NSC 26980, Muamycin (TN), CCRIS 414, Mitomycin [USAN:INN:BAN], UNII-50SG953SK6, HSDB 3239, C15H18N4O5, Mitomycin (USP/INN), EINECS 200-008-6, Mitomycin C, Streptomyces caespitosus, RCRA waste no. U010, AI3-26199, CHEBI:27504, 50SG953SK6, Mitomycin C, Streptomyces caespitosus, Carrier-Free, Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))-, Mitomycin C from Streptomyces caespitosus, Mitomycin C (JP15), DSSTox_CID_898, DSSTox_RID_75853, DSSTox_GSID_20898, 6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester), Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-, CAS-50-07-7, ((1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl)methyl carbamate, [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester), Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-, Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-, MLS002702984, (amino-methoxy-methyl-dioxo-[?]yl)methyl carbamate, 7-Amino-9.alpha.-methoxymitosane, Mitomycin [USAN:USP:INN:BAN], NCGC00095258-01, [(1aS,8S,8aR,8bS)-6-Amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2'',3'':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate, 7-Amino-9&alpha, Mitomycin C (JP17), CHEMBL105, D0NZ1U, D0Y0GH, AC1L1L1Q, SCHEMBL3760, CBiol_001927, BSPBio_001267, KBioGR_000607, KBioSS_000607, 1404-00-8, MLS001332654, Mitozytrex (TN) (Supergene), AMETYCIN pound notmitomycin C, GTPL7089, DTXSID2020898, KBio2_000607, KBio2_003175, KBio2_005743, KBio3_001073, KBio3_001074, EX-A501, MolPort-003-938-644, NWIBSHFKIJFRCO-WUDYKRTCSA-N, ZX-AFC000411, BCPP000410, Bio1_000213, Bio1_000702, Bio1_001191, Bio2_000464, Bio2_000944, HMS1362O09, HMS1792O09, HMS1990O09, HMS2089F16, HMS3403O09, Tox21_111493, BDBM50428658, GR-311, LS-136, MFCD00078109, s8146, ZINC30726187, AKOS015895703, Tox21_111493_1, ACN-038344, BCP9000285, CCG-208564, CS-0564, DB00305, KS-5148, IDI1_002219, SMP1_000307, NCGC00163468-02, NCGC00163468-03, NCGC00163468-05, NCGC00163468-06, AN-15420, Azirino(2',3':3,4)pyrrolo(1,2-a)indole-4,7-dione, 6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS-(1aalpha,8beta,8aalpha,8balpha))- (9CI), BC208285, CC-30970, HY-13316, SC-17000, SMR000058401, BCP0726000181, KB-145809, LS-173087, M2320, C06681, D00208, W-5071, AB00918689-03, AB00918689-04, 078M109, C-20147, Mitomycin C, Antibiotic for Culture Media Use Only, Q-201410, BRD-K59670716-001-02-6, BRD-K59670716-001-06-7, UNII-V03E10691T component NWIBSHFKIJFRCO-WUDYKRTCSA-N, WLN: T D3 B556 BN EM JV MVTTT&J GO1 H1OVZ KZ L1, Mitomycin C from Streptomyces caespitosus, >=970 mug/mg (USP XXIV), Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture, Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer, (1ar)-6-amino-8-(((aminoc arbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, (1ar)-6-amino-8-(((aminocarbonyl)oxy)methyl)-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0;{2,7}.0;{4,6}]trideca-1(9),11-dien-8-yl]methyl carbamate, [1aR-(1aalpha,8beta,8aalpha,8balpha)]-6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-alpha]indole-4,7-dione, [1aS-(1a?,8?,8a?,8b?)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 144085-53-0, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino[2',3':3, 4]pyrrolo[1,2-a]indole-4,7-dione, carbamate (ester), 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, carbamate (ester), 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-azirino[2',3':3,4]pyrrol o[1,2a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-azirino[2',3':3,4]pyrrolo[1,2a]indole-4,7-dione, 74349-48-7, 7481-68-7, Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl -, [1aS-(1aalpha,8beta,8aalpha,8balpha)]-, Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a- methoxy-5-methyl-, carbamate (ester), Azirino[2',4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b- hexahydro-8a-methoxy-5-methyl-, [1aR-(1a.alpha.,8.beta.,8a.alpha.,8b.alpha.)]-, Mitomycin C from Streptomyces caespitosus, >=98% (HPLC), potency: >=970 mug per mg (USP XXIV), gamma-irradiated, suitable for cell culture